Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

By A. Venook, D. Niedzwiecki, H. Lenz, F. Innocenti, B. Fruth, J. Meyerhardt, D. Schrag, C. Greene, B. O'Neil, J. Atkins and 13 more. Journal of the American Medical Association (JAMA), 2017

820 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology

View Paper: https://www.semanticscholar.org/paper/8ac3de47d5429f2a599cc5068ae85f49d5571418